{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:57:30Z","timestamp":1790542650114,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2025A1515140097"],"award-info":[{"award-number":["2025A1515140097"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372905"],"award-info":[{"award-number":["82372905"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573074"],"award-info":[{"award-number":["82573074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82674199"],"award-info":[{"award-number":["82674199"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2025A04J3464"],"award-info":[{"award-number":["2025A04J3464"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.mtbio.2026.103664","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:55:51Z","timestamp":1789055751000},"page":"103664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Biomaterial engineering of the tumor glycocalyx for cancer immunotherapy"],"prefix":"10.1016","volume":"40","author":[{"given":"Zhiyu","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiye","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9814-6945","authenticated-orcid":false,"given":"Li","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mtbio.2026.103664_bib1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cell.2020.04.010","article-title":"Adhesion protein structure, molecular affinities, and principles of cell-cell recognition","volume":"181","author":"Honig","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.mtbio.2026.103664_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nri.2016.54","article-title":"Origins of the cytolytic synapse","volume":"16","author":"de la Roche","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mtbio.2026.103664_bib3","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41580-020-00298-7","article-title":"Cell-cell interfaces as specialized compartments directing cell function","volume":"21","author":"Belardi","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mtbio.2026.103664_bib4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","article-title":"Global view of human protein glycosylation pathways and functions","volume":"21","author":"Schjoldager","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103664_bib5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41567-018-0186-9","article-title":"Physical biology of the cancer cell glycocalyx","volume":"14","author":"Kuo","year":"2018","journal-title":"Nat. Phys."},{"key":"10.1016\/j.mtbio.2026.103664_bib6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2026.103664_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41563-024-01808-0","article-title":"Immunoengineering can overcome the glycocalyx armour of cancer cells","volume":"23","author":"Park","year":"2024","journal-title":"Nat. Mater."},{"key":"10.1016\/j.mtbio.2026.103664_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nri.2018.3","article-title":"The tumour glyco-code as a novel immune checkpoint for immunotherapy","volume":"18","author":"Rodriguez","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mtbio.2026.103664_bib9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s43018-026-01200-8","article-title":"Immune implications and therapeutic opportunities of tumor glycosylation","volume":"7","author":"Hatinguais","year":"2026","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.mtbio.2026.103664_bib10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2009.12.008","article-title":"Metabolism, cell surface organization, and disease","volume":"139","author":"Dennis","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.mtbio.2026.103664_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103664_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.tcb.2015.12.004","article-title":"Cracking the glycome encoder: Signaling, trafficking, and glycosylation","volume":"26","author":"Bard","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.mtbio.2026.103664_bib13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","article-title":"Glycosylation: mechanisms, biological functions and clinical implications","volume":"9","author":"He","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"17","key":"10.1016\/j.mtbio.2026.103664_bib14","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/1873-3468.13541","article-title":"Translation of genome to glycome: role of the Golgi apparatus","volume":"593","author":"Pothukuchi","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mtbio.2026.103664_bib15","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/cac2.12610","article-title":"Altered glycosylation in cancer: molecular functions and therapeutic potential","volume":"44","author":"Xu","year":"2024","journal-title":"Cancer Commun."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103664_bib16","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041398","article-title":"Endocytic roles of glycans on proteins and lipids","volume":"16","author":"Johannes","year":"2024","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"20","key":"10.1016\/j.mtbio.2026.103664_bib17","doi-asserted-by":"crossref","first-page":"15603","DOI":"10.1021\/acs.chemrev.1c01032","article-title":"Glycoconjugates: synthesis, functional studies, and therapeutic developments","volume":"122","author":"Shivatare","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.mtbio.2026.103664_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-cellbio-120219-054401","article-title":"Glycocalyx curving the membrane: forces emerging from the cell exterior","volume":"37","author":"Kuo","year":"2021","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"40","key":"10.1016\/j.mtbio.2026.103664_bib19","doi-asserted-by":"crossref","first-page":"27215","DOI":"10.1021\/jacs.4c08818","article-title":"Sugar-Coated: can multivalent glycoconjugates improve upon nature's design?","volume":"146","author":"Leslie","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mtbio.2026.103664_bib20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/s41423-023-01074-1","article-title":"Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection","volume":"20","author":"Pinho","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103664_bib21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1039\/D2CS00736C","article-title":"Multivalent glycosystems for human lectins","volume":"52","author":"Martinez-Bailen","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.mtbio.2026.103664_bib22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-immunol-102419-035900","article-title":"Siglecs as immune cell checkpoints in disease","volume":"38","author":"Duan","year":"2020","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103664_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev-immunol-083024-030822","article-title":"Glycan-Binding proteins in immunity","volume":"44","author":"Rabinovich","year":"2026","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.mtbio.2026.103664_bib24","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.7150\/thno.80901","article-title":"Smaller size packs a stronger punch - recent advances in small antibody fragments targeting tumour-associated carbohydrate antigens","volume":"13","author":"Khilji","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.mtbio.2026.103664_bib25","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s43018-025-01025-x","article-title":"Nanotechnology for immuno-oncology","volume":"6","author":"Grippin","year":"2025","journal-title":"Nat. Cancer"},{"issue":"9","key":"10.1016\/j.mtbio.2026.103664_bib26","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.tips.2025.07.013","article-title":"Targeting glycosylation to enhance tumor immunotherapy","volume":"46","author":"Zhu","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.mtbio.2026.103664_bib27","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.mtbio.2026.103664_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123717","article-title":"Reprogramming the glycocalyx: advances in glycoengineering for immunomodulation and regenerative medicine","volume":"326","author":"Rana","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2026.103664_bib29","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1039\/D6CS00165C","article-title":"Clinical translation and landscape of stimuli-responsive nanomedicines and microscale therapeutics","volume":"55","author":"Kobzev","year":"2026","journal-title":"Chem. Soc. Rev."},{"issue":"42","key":"10.1016\/j.mtbio.2026.103664_bib30","doi-asserted-by":"crossref","first-page":"18022","DOI":"10.1021\/jacs.0c06793","article-title":"Glycan-Gold nanoparticles as multifunctional probes for multivalent lectin-carbohydrate binding: implications for blocking virus infection and nanoparticle assembly","volume":"142","author":"Budhadev","year":"2020","journal-title":"J. Am. Chem. Soc."},{"issue":"21","key":"10.1016\/j.mtbio.2026.103664_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202113528","article-title":"A glycoform-resolved dual-modal ratiometric Immunoassay improves the diagnostic precision for hepatocellular carcinoma","volume":"61","author":"Li","year":"2022","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"27","key":"10.1016\/j.mtbio.2026.103664_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202503004","article-title":"Cellular Glycocalyx affects nanoparticle access to cell membranes and uptake","volume":"37","author":"Bussin","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2026.103664_bib33","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41590-023-01498-x","article-title":"ST3GAL1 and \u03b2II-spectrin pathways control CAR T cell migration to target tumors","volume":"24","author":"Hong","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mtbio.2026.103664_bib34","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41578-021-00315-x","article-title":"Multifunctional biomolecule nanostructures for cancer therapy","volume":"6","author":"Wang","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"37","key":"10.1016\/j.mtbio.2026.103664_bib35","doi-asserted-by":"crossref","first-page":"49013","DOI":"10.1021\/acsami.4c09243","article-title":"In situ heparan sulfate-induced peptide self-assembly to overcome the cell surface Glycocalyx barrier for cancer treatment","volume":"16","author":"Pei","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"43","key":"10.1016\/j.mtbio.2026.103664_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202210059","article-title":"Materials for cell surface engineering","volume":"36","author":"Adebowale","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2026.103664_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202451008","article-title":"Lipid nanoparticle-mediated RNA delivery for immune cell modulation","volume":"54","author":"Kim","year":"2024","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103664_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202516608","article-title":"Shutting Down the 'Language encoder': a pathogen-derived nano-interferer disrupt sialylation metabolism and reprogram intercellular communication in glioblastoma","volume":"38","author":"Zhou","year":"2026","journal-title":"Adv. Mater."},{"issue":"28","key":"10.1016\/j.mtbio.2026.103664_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202401649","article-title":"Sialic acids blockade-based chemo-immunotherapy featuring cancer cell chemosensitivity and Antitumor immune response synergies","volume":"13","author":"Zhang","year":"2024","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2026.103664_bib40","doi-asserted-by":"crossref","first-page":"10304","DOI":"10.1073\/pnas.1608069113","article-title":"Precision glycocalyx editing as a strategy for cancer immunotherapy","volume":"113","author":"Xiao","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mtbio.2026.103664_bib41","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41589-020-0622-x","article-title":"Targeted glycan degradation potentiates the anticancer immune response in vivo","volume":"16","author":"Gray","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"669","key":"10.1016\/j.mtbio.2026.103664_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj1270","article-title":"Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade","volume":"14","author":"Stanczak","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"27","key":"10.1016\/j.mtbio.2026.103664_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/anie.1539868","article-title":"A bioinspired nanozyme enables glycoimmune therapy via precision sialoglycan trimming","volume":"65","author":"Guan","year":"2026","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"49","key":"10.1016\/j.mtbio.2026.103664_bib44","doi-asserted-by":"crossref","first-page":"54387","DOI":"10.1021\/acsami.0c15212","article-title":"Thermally triggered, cell-specific enzymatic Glyco-Editing: in situ regulation of lectin recognition and immune response on target cells","volume":"12","author":"Yu","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2026.103664_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/anie.8361803","article-title":"Chemically masked aPD-L1-Sialidase conjugate for tumor-specific desialylation and immunotherapy","volume":"65","author":"Zeng","year":"2026","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.mtbio.2026.103664_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.139953","article-title":"A nanobody-enzyme fusion protein targeting PD-L1 and sialic acid exerts anti-tumor effects by C-type lectin pathway-mediated tumor associated macrophages repolarizing","volume":"298","author":"Tong","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.mtbio.2026.103664_bib47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41551-024-01202-w","article-title":"Targeted desialylation and cytolysis of tumour cells by fusing a sialidase to a bispecific T-cell engager","volume":"8","author":"Yang","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.mtbio.2026.103664_bib48","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2300366120","article-title":"Targeted glycan degradation potentiates cellular immunotherapy for solid tumors","volume":"120","author":"Wu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mtbio.2026.103664_bib49","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1158\/0008-5472.CAN-25-3070","article-title":"A probiotic approach targeting hypersialylation revives CD8+ T-cell immunity and boosts photodynamic therapy efficacy in solid tumors","volume":"86","author":"Wang","year":"2026","journal-title":"Cancer Res."},{"issue":"33","key":"10.1016\/j.mtbio.2026.103664_bib50","doi-asserted-by":"crossref","first-page":"10362","DOI":"10.1021\/acs.nanolett.4c03049","article-title":"Sialidase-Chimeric bioengineered bacteria for tumor-sialoglycan-triggered solid tumor therapy","volume":"24","author":"Chen","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2026.103664_bib51","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12967-022-03714-y","article-title":"Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal\/GalNAc epitopes elicit anti-tumor immunity","volume":"20","author":"Huang","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.mtbio.2026.103664_bib52","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2529792123","article-title":"Mucinase-engineered cell membrane nanovesicles degrade the glycocalyx shield to potentiate antitumor immunity","volume":"123","author":"Geng","year":"2026","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103664_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202504460","article-title":"Photo-Controlled MUC1 ablation via steric locking of Turn-On reactors enhances pyroptosis-immunotherapy of triple negative breast cancer","volume":"38","author":"Yang","year":"2026","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103664_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202303337","article-title":"Nanointegrative glycoengineering-activated necroptosis of triple negative breast cancer stem cells enables self-amplifiable immunotherapy for systemic tumor rejection","volume":"13","author":"Zhao","year":"2024","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2026.103664_bib55","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.7150\/thno.60211","article-title":"Generation of triacyl lipopeptide-modified glycoproteins by metabolic glycoengineering as the neoantigen to boost anti-tumor immune response","volume":"11","author":"Zhao","year":"2021","journal-title":"Theranostics"},{"issue":"20","key":"10.1016\/j.mtbio.2026.103664_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202319849","article-title":"Ultra-Galactocation to sialic acid on tumor cells with A penta-functional dendritic probe for enhanced immune-killing","volume":"63","author":"Yang","year":"2024","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.mtbio.2026.103664_bib57","article-title":"Triply enhanced immunotherapy via dual glycan reforming integrated with perforation","volume":"11","author":"Yang","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"14","key":"10.1016\/j.mtbio.2026.103664_bib58","article-title":"Membrane-Fusion-Mediated Multiplex engineering of Tumor cell surface glycans for enhanced NK cell therapy","volume":"35","author":"Zheng","year":"2023","journal-title":"Adv. Mater."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103664_bib59","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1021\/acsabm.1c00507","article-title":"Sialidase-Conjugated \"NanoNiche\" for efficient immune checkpoint blockade therapy","volume":"4","author":"Zhou","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.mtbio.2026.103664_bib60","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejpb.2021.05.014","article-title":"Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression","volume":"165","author":"Lu","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.mtbio.2026.103664_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba4024","article-title":"Engineering autologous tumor cell vaccine to locally mobilize antitumor immunity in tumor surgical bed","volume":"6","author":"Fang","year":"2020","journal-title":"Sci. Adv."},{"issue":"39","key":"10.1016\/j.mtbio.2026.103664_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202502758","article-title":"Signal transducer nanoparticles enable Siglec-10\/G blockade immunotherapy for breast cancer treatment","volume":"37","author":"Meng","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2026.103664_bib63","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.apsb.2022.08.009","article-title":"Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma","volume":"13","author":"Choi","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2026.103664_bib64","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jconrel.2023.01.075","article-title":"Engineering nanoparticles boost TNBC therapy by CD24 blockade and mitochondrial dynamics regulation","volume":"355","author":"Zhao","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.mtbio.2026.103664_bib65","article-title":"Killing two birds with one stone: Siglec-15 targeting integrated bioactive glasses hydrogel for treatment of breast cancer bone metastasis","volume":"29","author":"Liu","year":"2024","journal-title":"Mater. Today Bio"},{"issue":"29","key":"10.1016\/j.mtbio.2026.103664_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202107787","article-title":"Siglec15 checkpoint blockade for simultaneous immunochemotherapy and osteolysis inhibition in lung adenocarcinoma spinal metastasis via a hollow nanoplatform","volume":"18","author":"Liang","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2026.103664_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118149","article-title":"Targeting galectin-4 with glycoconjugates of varying architectures: a multivalency \u00e9tude with accent on anti-tumor effect and protection against apoptosis","volume":"300","author":"Vopalenska","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"19","key":"10.1016\/j.mtbio.2026.103664_bib68","doi-asserted-by":"crossref","first-page":"22159","DOI":"10.1021\/acsami.1c02116","article-title":"An antibody-like polymeric nanoparticle removes intratumoral Galectin-1 to enhance antitumor T-Cell responses in cancer immunotherapy","volume":"13","author":"Gu","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2026.103664_bib69","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2016.02.032","article-title":"Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration","volume":"227","author":"Van Woensel","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.mtbio.2026.103664_bib70","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41598-017-01279-1","article-title":"Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy","volume":"7","author":"Van Woensel","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mtbio.2026.103664_bib71","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s42003-024-05891-6","article-title":"Tumor-targeted nanodrug FSGG\/siGal-9 for transdermal photothermal immunotherapy of melanoma","volume":"7","author":"Ren","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.mtbio.2026.103664_bib72","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11060-023-04257-y","article-title":"T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma","volume":"162","author":"Li","year":"2023","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.mtbio.2026.103664_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123511","article-title":"Nanoparticles-mediated intratumoral gene editing targeting PD-L1 and Galectin-9 for improved cancer immunotherapy","volume":"324","author":"Fang","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2026.103664_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1766555","article-title":"Glycoengineering CAR-T cells to overcome galectin-3-mediated immunosuppression","volume":"17","author":"Lau","year":"2026","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103664_bib75","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1021\/acscentsci.5c00510","article-title":"Targeting sialidase to PD1 enhances T cell function and tumor control","volume":"11","author":"Garabedian","year":"2025","journal-title":"ACS Cent. Sci."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103664_bib76","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ymthe.2021.11.014","article-title":"Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase","volume":"30","author":"Durgin","year":"2022","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103664_bib77","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1021\/acs.biomac.3c00916","article-title":"Ex vivo surface decoration of phenylboronic acid onto natural killer cells for sialic acid-mediated versatile cancer cell targeting","volume":"25","author":"Jangid","year":"2024","journal-title":"Biomacromolecules"},{"issue":"30","key":"10.1016\/j.mtbio.2026.103664_bib78","article-title":"Glycan covalent targeting chimera-based T-Cell glycoengineering for boosting immunotherapy","volume":"31","author":"Wang","year":"2025","journal-title":"Chemistry"},{"key":"10.1016\/j.mtbio.2026.103664_bib79","article-title":"One-Step glycoengineering of NK cells with high-affinity siglec ligands for cancer immunotherapy","volume":"13","author":"Hu","year":"2026","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"7","key":"10.1016\/j.mtbio.2026.103664_bib80","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1002\/anie.202005934","article-title":"Glycoengineering of NK cells with glycan ligands of CD22 and selectins for B-Cell lymphoma therapy","volume":"60","author":"Hong","year":"2021","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103664_bib81","article-title":"Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors","volume":"6","author":"Abrantes","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.mtbio.2026.103664_bib82","doi-asserted-by":"crossref","first-page":"15148","DOI":"10.1073\/pnas.1920662117","article-title":"Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides","volume":"117","author":"Sharma","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"33","key":"10.1016\/j.mtbio.2026.103664_bib83","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1002\/smll.201403838","article-title":"Glycocalyx-Mimicking nanoparticles for stimulation and polarization of macrophages via specific interactions","volume":"11","author":"Su","year":"2015","journal-title":"Small"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103664_bib84","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1021\/acs.biomac.8b00305","article-title":"Glycocalyx-Mimicking nanoparticles improve Anti-PD-L1 cancer immunotherapy through reversion of tumor-associated macrophages","volume":"19","author":"Zhang","year":"2018","journal-title":"Biomacromolecules"},{"issue":"42","key":"10.1016\/j.mtbio.2026.103664_bib85","doi-asserted-by":"crossref","first-page":"38838","DOI":"10.1021\/jacs.5c14740","article-title":"Synergistic programming of macrophages by hybrid glycocalyx-inspired nanoparticles for adoptive cell therapy","volume":"147","author":"Yin","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103664_bib86","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/acsmacrolett.5c00712","article-title":"Nanovaccine based on glycocalyx-mimicking nanovehicle to potentiate the immunogenicity of neoantigen","volume":"15","author":"Shi","year":"2026","journal-title":"ACS Macro Lett."},{"key":"10.1016\/j.mtbio.2026.103664_bib87","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1186\/s12951-024-03051-w","article-title":"Ultrasound nanodroplets loaded with Siglec-G siRNA and Fe\u2083O\u2084 activate macrophages and enhance phagocytosis for immunotherapy of triple-negative breast cancer","volume":"22","author":"Yin","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2026.103664_bib88","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1016\/j.apsb.2023.07.012","article-title":"Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy","volume":"13","author":"Liu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2026.103664_bib89","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2519819123","article-title":"Synthetic SIGLEC9-based chimeric switch receptor augments the efficacy of CAR macrophages against glioblastoma","volume":"123","author":"Fu","year":"2026","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mtbio.2026.103664_bib90","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41598-023-50957-w","article-title":"An N-glycome tissue atlas of 15 human normal and cancer tissue types determined by MALDI-imaging mass spectrometry","volume":"14","author":"Wallace","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mtbio.2026.103664_bib91","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146945","article-title":"Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis","volume":"6","author":"Scupakova","year":"2021","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103664_bib92","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ccell.2019.06.006","article-title":"Glycosylation in the era of cancer-targeted therapy: where are we heading?","volume":"36","author":"Mereiter","year":"2019","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.mtbio.2026.103664_bib93","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1016\/j.cell.2025.09.001","article-title":"Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens","volume":"188","author":"Zhou","year":"2025","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103664_bib94","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1039\/D3CS00842H","article-title":"Glycan-specific molecularly imprinted polymers towards cancer diagnostics: merits, applications, and future perspectives","volume":"53","author":"Li","year":"2024","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.mtbio.2026.103664_bib95","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41573-020-00093-1","article-title":"The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans","volume":"20","author":"Smith","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2026.103664_bib96","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.addr.2021.02.019","article-title":"Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma","volume":"172","author":"Liu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2026.103664_bib97","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2026.103664_bib98","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2174\/0929867328666210713094722","article-title":"Use of exogenous enzymes in human therapy: approved drugs and potential applications","volume":"29","author":"Cioni","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.mtbio.2026.103664_bib99","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cbpa.2021.03.005","article-title":"Adapting protein sequences for optimized therapeutic efficacy","volume":"64","author":"Dellas","year":"2021","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.mtbio.2026.103664_bib100","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1042\/BST20211203","article-title":"Transgenic mouse models to study the physiological and pathophysiological roles of human Siglecs","volume":"50","author":"McCord","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.mtbio.2026.103664_bib101","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","article-title":"Humanized mouse models for immuno-oncology research","volume":"20","author":"Chuprin","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103664_bib102","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","article-title":"Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment","volume":"24","author":"Polak","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2026.103664_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115946","article-title":"Methods to generate site-specific conjugates of antibody and protein","volume":"30","author":"Park","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"30","key":"10.1016\/j.mtbio.2026.103664_bib104","doi-asserted-by":"crossref","first-page":"36052","DOI":"10.1021\/acsami.3c08666","article-title":"Programmable monodisperse glyco-multivalency using self-assembled coordination cages as scaffolds","volume":"15","author":"Pritchard","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103664_bib105","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.1021\/acsnano.2c02084","article-title":"Quantification of available ligand density on the surface of targeted liposomal nanomedicines at the single-particle level","volume":"16","author":"Chen","year":"2022","journal-title":"ACS Nano"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426009099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426009099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:12:09Z","timestamp":1790539929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426009099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":105,"alternative-id":["S2590006426009099"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103664","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomaterial engineering of the tumor glycocalyx for cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103664"}}